(Total Views: 135)
Posted On: 10/22/2019 11:00:42 AM
Post# of 103742
$JAGX News Article - Jaguar Health's Study Shows Mytesi (Crofelemer) May Support Treatment of Diarrhea in Cancer Patients Receiving Targeted Therapy While Also Enabling Maintenance and Tolerability of a Higher Dose of the Selected TKI https://marketwirenews.com/news-releases/jagu...93138.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
